Elicera Therapeutics AB (publ) (STO:ELIC)

Elicera Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	58.13	24.85	26.4	29.38	43.82	52.39
Cash & Short-Term Investments	58.13	24.85	26.4	29.38	43.82	52.39
Cash Growth	46.56%	-5.88%	-10.15%	-32.95%	-16.36%	353.04%
Other Receivables	1.47	0.05	0.88	0.34	0.33	0.2
Receivables	1.47	0.05	0.88	0.34	0.33	0.2
Prepaid Expenses	-	2.03	0.28	0.45	1.65	1.62
Other Current Assets	-	-	-	-	-0	-0.01
Total Current Assets	59.6	26.93	27.57	30.17	45.8	54.21
Long-Term Investments	-	-	0	0	0.48	0.48
Other Intangible Assets	-	-	-	0.01	0.02	0.04
Other Long-Term Assets	-	0.49	-	-	-0	0.01
Total Assets	59.6	27.42	27.57	30.18	46.31	54.74

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.88	2.57	2.04	0.88	0.73	2.05
Accrued Expenses	1.31	1.24	4.4	12.5	12.53	0.31
Current Income Taxes Payable	-	-	-	-	0.01	0
Other Current Liabilities	0.15	0.25	0.35	0.4	0.24	0.14
Total Current Liabilities	3.35	4.06	6.8	13.78	13.51	2.5
Total Liabilities	3.35	4.06	6.8	13.78	13.51	2.5

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.8	2.04	1.47	0.83	0.83	0.83
Additional Paid-In Capital	64.77	106.06	86.62	66.79	66.79	66.79
Retained Earnings	-11.32	-84.73	-67.33	-51.22	-34.82	-15.38
Comprehensive Income & Other	-	-	-	-	-0	-0
Shareholders' Equity	56.25	23.36	20.77	16.4	32.8	52.24
Total Liabilities & Equity	59.6	27.42	27.57	30.18	46.31	54.74

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash (Debt)	58.13	24.85	26.4	29.38	43.82	52.39
Net Cash Growth	46.56%	-5.88%	-10.15%	-32.95%	-16.36%	353.04%
Net Cash Per Share	-	0.54	0.84	1.49	2.21	3.27
Filing Date Shares Outstanding	-	48.54	35.09	19.78	19.78	19.78
Total Common Shares Outstanding	-	48.54	35.09	19.78	19.78	19.78
Working Capital	56.25	22.87	20.77	16.39	32.29	51.71
Book Value Per Share	-	0.48	0.59	0.83	1.66	2.64
Tangible Book Value	56.25	23.36	20.77	16.39	32.78	52.2
Tangible Book Value Per Share	-	0.48	0.59	0.83	1.66	2.64

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error